We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Acuity Brands
AYI
$10.1B
| $19.9M | 0.07% |
75,134
-9,278
| -11% | -$2.47M |
|
202
Vanguard High Dividend Yield ETF
VYM
$81.3B
| $19.8M | 0.07% |
274,862
+64,860
| +31% | +$4.71M |
|
203
JB Hunt Transport Services
JBHT
$26.4B
| $19.8M | 0.07% |
243,619
+5,237
| +2% | +$428K |
|
204
Campbell Soup
CPB
$6.67B
| $19.7M | 0.07% |
359,671
| – | – |
|
205
Verizon
VZ
$198B
| $19.4M | 0.07% |
372,344
-4,419
| -1% | -$237K |
|
|
CERN
206
DELISTED
Cerner Corp
CERN
| $19.3M | 0.07% |
312,926
+6,503
| +2% | +$410K |
|
|
CLGX
207
DELISTED
Corelogic, Inc.
CLGX
| $19.1M | 0.07% |
485,976
+35,436
| +8% | +$1.41M |
|
|
LNKD
208
DELISTED
LinkedIn Corporation
LNKD
| $18.8M | 0.06% |
98,488
-54,398
| -36% | -$10.4M |
|
209
Willis Towers Watson
WTW
$28.6B
| $18.4M | 0.06% |
138,396
-9,417
| -6% | -$1.17M |
|
|
210
Bristol-Myers Squibb
BMY
$128B
| $18.4M | 0.06% |
340,569
-7,755,824
| -96% | -$498M |
|
211
AT&T
T
$167B
| $18.3M | 0.06% |
596,867
+49,536
| +9% | +$1.57M |
|
212
Renasant Corp
RNST
$4B
| $18.3M | 0.06% |
543,462
+4,079
| +0.8% | +$137K |
|
213
Schwab US Broad Market ETF
SCHB
$42.8B
| $18.3M | 0.06% |
2,095,158
+188,970
| +10% | +$1.64M |
|
214
Center Bancorp
CNOB
$1.65B
| $18.2M | 0.06% |
1,008,102
+69,126
| +7% | +$1.2M |
|
215
Suncor Energy
SU
$75.6B
| $18.1M | 0.06% |
652,438
-56,735
| -8% | -$1.55M |
|
216
Mettler-Toledo International
MTD
$27B
| $17.8M | 0.06% |
42,512
+3,950
| +10% | +$1.57M |
|
|
MMP
217
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $17.7M | 0.06% |
249,530
-7,389
| -3% | -$527K |
|
218
Guidewire Software
GWRE
$12.4B
| $17.6M | 0.06% |
294,118
+31,174
| +12% | +$1.92M |
|
219
Neurocrine Biosciences
NBIX
$17.7B
| $17.6M | 0.06% |
347,270
+25,957
| +8% | +$1.29M |
|
220
CVS Health
CVS
$137B
| $17.5M | 0.06% |
196,931
+8,036
| +4% | +$759K |
|
221
OceanFirst Financial
OCFC
$1.7B
| $17.4M | 0.06% |
903,149
+98,559
| +12% | +$1.88M |
|
222
Federal Signal
FSS
$7.22B
| $17.4M | 0.06% |
1,309,793
+11,491
| +0.9% | +$151K |
|
223
Becton Dickinson
BDX
$43.8B
| $17.3M | 0.06% |
98,747
+11,133
| +13% | +$1.9M |
|
|
NGHC
224
DELISTED
National General Holdings Corp
NGHC
| $17.3M | 0.06% |
776,210
+5,718
| +0.7% | +$125K |
|
225
Brookfield Infrastructure Partners
BIP
$18.6B
| $17.2M | 0.06% |
836,334
-26,532
| -3% | -$510K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.